Co-Authors
This is a "connection" page, showing publications co-authored by Jason Zucker and Anne-Catrin Uhlemann.
Connection Strength
1.181
-
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021 09; 597(7878):703-708.
Score: 0.241
-
Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City. J Clin Med. 2021 Aug 11; 10(16).
Score: 0.240
-
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis. 2021 Jun; 8(6):ofab201.
Score: 0.236
-
Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality. Open Forum Infect Dis. 2021 Feb; 8(2):ofab003.
Score: 0.231
-
Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Transpl Infect Dis. 2021 Aug; 23(4):e13637.
Score: 0.059
-
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak. PLoS One. 2021; 16(4):e0249349.
Score: 0.059
-
Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrob Agents Chemother. 2021 03 18; 65(4).
Score: 0.058
-
Cerebrospinal Analysis in Patients With COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa501.
Score: 0.057